ANRO ALTO NEUROSCIENCE INC
2026Q1 · CUSIP 02157Q109 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
108
Δ holders QoQ
+10
Breadth percentile
Top 29%
Whale holders
59
Δ whales
+10
Inst. holding value
$602M
New positions
24
Closed positions
14
Price momentum (1Q)
+13.2%
Put / Call
1/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 1 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q3 | Top 20% | -30.7% | -36.3% |
Options Sentiment
Put holders
1
QoQ: +1
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.43
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-30.5%
Debt ratio
11.9%
FCF (TTM)
-$63M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.